NTGN stock forecast
Our latest prediction for Neon Therapeutics, Inc.'s stock price was made on the June 29, 2018 when the stock price was at 12.60$.
In the short term (2weeks), NTGN's stock price should outperform the market by 5.25%. During that period the price should oscillate between -2.28% and +4.02%.
In the medium term (3months), NTGN's stock price should outperform the market by 10.17%. During that period the price should oscillate between -5.09% and +10.96%.Get email alerts
About Neon Therapeutics, Inc.
Neon Therapeutics, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -2.22$ per share.
The book value per share is 4.92$
Three months stock forecastJune 29, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|